Evaluation of IL-3, IL-5, and IL-6 concentration in the follicular fluid of women with endometriosis: A cross-sectional study


Background: Endometriosis is associated with abnormal immunologic responses and combined inflammatory and anti-inflammatory conditions.

Objective: This study aims to investigate follicular fluid (FF) concentration of interleukin (IL)-3, IL-5, and IL-6 in women with and without endometriosis.

Materials and Methods: In this cross-sectional study 68 women who were referred to the in vitro fertilization center of Imam Reza hospital in Mashhad during 2018 were selected randomly. Leaves of cytokines in the FF samples were evaluated in the endometriosis and the control group (n = 34/each). The diagnostic accuracy of cytokines and clinical characteristics were evaluated.

Results: IL-3 and IL-6 were significantly changed in the FF of the women with endometriosis compared with the control group (p = 0.04, and p < 0.01, respectively), and the mean concentration of IL-5 in the endometriosis group was lower than in the control group (p = 0.5), but this was not significant. There were significant differences in the menstrual cycle, dyspareunia, and dysmenorrhea between the groups (p < 0.01, p = 0.04, and p = 0.02, respectively). The diagnostic accuracy of IL-3 and IL-6 in the FF was low, with the area under the curve of 0.614 and 0.645, respectively.

Conclusion: Although none of the cytokines had a predictive value for endometriosis, the decreased levels of IL-3 and increased levels of IL-6 in the FF samples of women with endometriosis, and risk factors, including irregular menstrual cycle, dyspareunia, and dysmenorrhea, could be associated with the pathogenesis of this painful disease.

Key words: Interleukin-3, Interleukin-5, Interleukin-6, Follicular fluid, Endometriosis.

[1] Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 2017; 6: 34–41.

[2] Mehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life 2014; 7: 349– 357.

[3] Zhou WJ, Yang HL, Shao J, Mei J, Chang KK, Zhu R, et al. Anti-inflammatory cytokines in endometriosis. Cell Mol Life Sci 2019; 76: 2111–2132.

[4] Sharpe-Timms KL, Nabli H, Zimmer RL, Birt JA, Davis JW. Inflammatory cytokines differentially up-regulate human endometrial haptoglobin production in women with endometriosis. Hum Reprod 2010; 25: 1241–1250.

[5] Jiang L, Yan Y, Liu Zh, Wang Y. Inflammation and endometriosis. Front Biosci 2016; 21: 941–948.

[6] Zhang T, De Carolis C, Man GChW, Wang ChCh. The link between immunity, autoimmunity and endometriosis: A literature update. Autoimmun Rev 2018; 17: 945–955.

[7] da Gama Coelh Riccio L, Santulli P, Marcellin L, Abrao MS, Batteux F, Chapron C. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 2018; 50: 39–49.

[8] Jorgensen H, Hill AS, Beste MT, Kumar MP, Chiswick E, Fedorcsak P, et al. Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility. Fertil Steril 2017; 107: 1191–1199.

[9] Li Sh, Fu X, Wu T, Yang L, Hu Ch, Wu RJ. Role of interleukin-6 and its receptor in endometriosis. Med Sci Monit 2017; 23: 3801–3807.

[10] Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789–1799.

[11] Samimi M, Pourhanifeh MH, Mehdizadehkashi A, Eftekhar T, Asemi Z. The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression. J Cell Physiol 2019; 234: 19384–19392.

[12] Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001; 76: 1–10.

[13] Monsanto SP, Edwards AK, Zhou J, Nagarkatti P, Nagarkatti M, Young SL, et al. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril 2016; 105: 968–977.

[14] Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: Regulators of inflammation. Immunity 2019; 50: 796–811.

[15] Jiang J, Jiang Zh, Xue M. Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis. Gynecol Endocrinol 2019; 35: 571– 575.

[16] Mosbah A, Nabiel Y, Khashaba E. Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis. Int J Gynaecol Obstet 2016; 134: 247–251.

[17] Kashanian M, Sariri E, Vahdat M, Ahmari M, Moradi Y, Sheikhansari N. A comparison between serum levels of interleukin-6 and CA125 in patients with endometriosis and normal women. Med J Islam Repub Iran 2015; 29: 280.

[18] AL-Tai THH, AL-Hadithi HS, Abdulsalam HS. The role of serum IL-6 changes in evaluation of endometriosis. J Fac Med Baghdad 2013; 55: 158–161.

[19] Hadisaputra W. Clinical signs, symptoms and serum level of interleukin-6 and tumor necrosis factor in women with or without endometriosis. Asian Pac J Reprod 2013; 2: 142–145.

[20] Ashrafi M, Jahanian Sadatmahalleh Sh, Akhoond MR, Talebi M. Evaluation of risk factors associated with endometriosis in infertile women. Int J Fertil Steril 2016; 10: 11–21.

[21] Wei M, Cheng Y, Bu H, Zhao Y, Zhao W. Length of menstrual cycle and risk of endometriosis: A metaanalysis of 11 case-control studies. Medicine 2016; 95: e2922.